PharmExec Picks:
Having trouble viewing this e-mail? Click here.
feed back

Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE


Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what's trending on social media.

Top 5 Stories :
Express Scripts to Center Stage
Pharm Exec profiles Express Scripts' Chief Medical Officer, Dr. Steve Miller, whose rise to prominence as an articulate critic of drug industry prices symbolizes the growing clout of America's largest pharmacy benefit manager.
Read more
Sponsored
learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study. Read more
 
ABC: A Burgeoning Giant Steps Out
AmerisourceBergen [ABC], the $100 billion sourcing and distribution behemoth, is building on its success in the US market to expand internationally through a series of strategic ties with foreign enterprise partners.
Read more
Marketing: Ready for the Next War?
Pharmaceutical marketing organizations are usually better equipped to fight the last war rather than the next one. But success, in war and in marketing, usually goes to the side which accepts and acts on the challenges of the new environment more rapidly.
Read more
What's Wrong with the Annual Sales Kickoff: And How to Fix it
Sales teams look to national gatherings to address mounting in-market challenges—from diminished physician access and cross-selling demands to heightened regulatory and competitive pressures.
Read more
EU Strengthens Transatlantic Links
The European Union's extensive links with the US FDA and Health Canada have reached a further level of maturity, writes Peter O' Donnell.
Read more
Trending on Social Media :
Compassionate Use Debate Heats Up
Patient access to critical experimental medicines continues to grab public attention, as states enact “Right-to-Try” laws and Congress eyes establishing a national policy to provide not-yet-approved therapies to terminally ill patients.
Read more
PCORI to Compare Hep C Treatments
PCORI is launching a $50 million program to fund research on the comparative effectiveness of various approaches for diagnosing and treating hepatitis C.
Read more
Key Obamacare Actions for Rx Manufacturers in 2015
Obamacare developments for the American Rx industry in 2015 could cause various actions with potential for substantial uncertainty for the U.S. pharmaceutical industry next year.
Read more
Follow Us